Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
J Int Med Res. 2020 Nov;48(11):300060520957551. doi: 10.1177/0300060520957551.
Interventional pain procedures (IPPs) may be necessary for some cancer patients when conservative treatment fails. However, many IPPs are often delayed or cancelled for cancer patients who are referred to the pain clinic.
We retrospectively analyzed the reasons for such cancellations to identify clinically avoidable causes of the delay in IPP.
We enrolled 350 cancer patients who were referred to our pain clinic for an IPP between March 2016 and February 2018. There were 213 (60.9%) cases that were cancelled, among which 115 (54%) cases were potentially avoidable and 98 (46%) were unavoidable. The most common reasons for cancellation were patient-derived factors, which accounted for 85 (39.9%) cases. Patient refusal was a common reason for cancellation, with 33 (15.5%) cases attributed to this cause. The primary avoidable causes of cancellation were a recommendation that the patient continue with their current pharmacological pain treatment, conflict with another planned treatment, and pain characteristics that were not suitable for an IPP. Together, these accounted for 76.5% of all avoidable cancellations.
Comprehensive and accurate pain assessments before IPP may result in more favorable outcomes for the efficient use of medical resource and effective pain relief in cancer patients.
当保守治疗失败时,一些癌症患者可能需要介入性疼痛治疗(IPP)。然而,许多癌症患者在被转介到疼痛诊所后,IPP 经常被延迟或取消。
我们回顾性分析了这些取消的原因,以确定 IPP 延迟的临床可避免原因。
我们招募了 350 名在 2016 年 3 月至 2018 年 2 月期间被转介到我们疼痛诊所进行 IPP 的癌症患者。其中有 213 例(60.9%)被取消,其中 115 例(54%)是潜在可避免的,98 例(46%)是不可避免的。取消的最常见原因是患者因素,占 85 例(39.9%)。患者拒绝是取消的常见原因,其中 33 例(15.5%)归因于此原因。取消的主要可避免原因是建议患者继续当前的药物疼痛治疗、与另一种计划治疗相冲突以及疼痛特征不适合 IPP。这些原因共占所有可避免取消的 76.5%。
在进行 IPP 之前进行全面和准确的疼痛评估可能会导致更有利于有效利用医疗资源和缓解癌症患者疼痛的结果。